Diagnostic and Prognostic Significance of Circulating Oxidative Stress and Blood Cell Mitochondrial Respiration in Pre-Capillary Pulmonary Hypertension

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study aims to understand how blood cell (including peripheral blood mononuclear cells ((PBMCs) or platelets) function and oxidative stress can help physicians detect and predict the course of pre-capillary pulmonary hypertension. We hypothesize that changes in the mitochondrial function of blood cells and oxidative stress may be early markers of disease progression and severity. The study will also explore how these blood markers relate to routine clinical and heart function measurements, such as echocardiography, right heart catheterization, 6-minute walk tests, and functional status, to see if they can help monitor patients over time and guide personalized care. This is a non-interventional study. Blood samples will be collected during routine visits planned for diagnosis and follow-up. The study will include 120 patients diagnosed with pre-capillary pulmonary hypertension, who will be followed for 3 years. Blood samples will be taken up to three times per year to measure mainly oxidative stress and mitochondrial function in blood cells. These measurements will be compared with clinical tests to see if they can help predict the course of the disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult patients (≥18 years) diagnosed with pre-capillary pulmonary hypertension confirmed by right heart catheterization

• Patients classified according to the international clinical classification:

‣ Group 1: Pulmonary arterial hypertension (PAH)

⁃ Group 3: Pulmonary hypertension associated with chronic respiratory diseases and/or hypoxia

⁃ Group 4: Chronic thromboembolic pulmonary hypertension (CTEPH)

• Patients scheduled for routine clinical follow-up and/or right heart catheterization at the study center.

• Ability and willingness to provide informed consent for participation and data analysis.

Locations
Other Locations
France
Hôpitaux Universitaires de Strasbourg - Service Physiologie explorations fonctionnelles
RECRUITING
Strasbourg
Contact Information
Primary
Marianne RIOU
marianne.riou@chru-strasbourg.fr
+ 33 3 69 55 11 45
Time Frame
Start Date: 2025-09
Estimated Completion Date: 2026-06
Participants
Target number of participants: 120
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Strasbourg, France

This content was sourced from clinicaltrials.gov